Product Name :
Anti-CD30/TNFRSF8(Brentuximab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human TNFRSF8/CD30
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-CD30/TNFRSF8(Brentuximab Biosimilar) Antibody is a biosimilar antibody directed against Human TNFRSF8/CD30. | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: Human TNFRSF8/CD30 | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-CD30/TNFRSF8(Brentuximab Biosimilar) Antibody is a biosimilar antibody directed against Human TNFRSF8/CD30.
Immunogen:
Host :
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{1799633-27-4} medchemexpress|{1799633-27-4} Purity & Documentation|{1799633-27-4} In stock|{1799633-27-4} supplier} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.{{908112-43-6} site|{908112-43-6} Biological Activity|{908112-43-6} Purity|{908112-43-6} custom synthesis} The actual dilution used must be determined empirically.PMID:20301549